Hawaiian Eye/Retina Meeting

Hawaiian Eye/Retina Meeting

Source:

Rishi P. Singh, MD

May 08, 2021
1 min watch
Save

VIDEO: Brolucizumab demonstrates drying effect in patients with DME

Source:

Rishi P. Singh, MD

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

WAILEA, Hawaii — In this video from Hawaiian Eye, Rishi P. Singh, MD, discusses results from the KITE and KESTREL trials of brolucizumab vs. aflibercept in the treatment of diabetic macular edema.

The 52-week endpoint results, recently presented at the virtual Association for Research in Vision and Ophthalmology meeting, showed a higher proportion of patients with fluid resolution in the brolucizumab (Beovu, Novartis) arm than the aflibercept (Eylea, Regeneron) arm.